FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Jan 14, 2020
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on January 14, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- ImpactLife
- Inspection Date
- January 14, 2020
- Product Type
- Biologics
View Company Profile
ID · bb361849-a210-49c3-ab66-a8e56b399f3f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1115857
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of ImpactLife
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 20, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 8, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 25, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1332592 - 2026-08-14
- FDA Inspection 1047630 - 2018-03-20
- FDA Inspection 955078 - 2015-12-08
- FDA Inspection 855749 - 2013-11-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.